Among them, the contradiction between supply and demand of cancer treatment in third-tier and below cities is prominent. In order to alleviate the contradiction between supply and demand, cancer treatment in third-tier and below cities will develop rapidly. In the future, private hospitals in the cancer treatment industry have great development potential.
Cancer has become the leading cause of death in China.
According to the data released by the National Cancer Center in 20 19, malignant tumor deaths accounted for 23.438+0% of all deaths in China, and cancer has become the first cause of death in China. The number of cancer cases in China is increasing year by year. According to the data of the International Center for Research on Cancer (IARC) of the World Health Organization, the number of cancer cases in China increased from 3.95 million in 20 15 to 4.57 million in 2020.
The growth of cancer patients has promoted the growth of cancer treatment market.
With the growth of cancer patients in China, the demand for cancer medical services in China is also increasing. According to yost Sullivan's data, from 20 15 to 20 19, the market scale of cancer medical service in China increased from 231400 million yuan to 37 10 billion yuan, with a compound annual growth rate of 12.53%. According to yost Sullivan's prediction, from 2020 to 2025, the tumor medical service market in China is expected to grow to 700.3 billion yuan, with a compound annual growth rate of 1 1.54%.
Third-tier and below cities will develop rapidly
There is a great demand for tumor treatment in third-tier and below cities in China. According to yost Sullivan's data, in 20 19 years, the market scale of cancer medical services in third-tier and below cities in China accounted for the largest proportion, reaching 57.4%, and the market scale increased year by year. In terms of the number of patients, the number of cancer patients in third-tier cities and below is the largest, accounting for 75. 1%.
The contradiction between supply and demand of cancer treatment in third-tier and below cities in China is prominent. From the perspective of tumor treatment equipment, China's tumor treatment equipment is mainly distributed in first-tier cities and second-tier cities. In 20 19, the proportion of radiotherapy equipment per million population in third-tier and below cities in China was lower than that in first-and second-tier cities, accounting for 22.4%. In the future, the cancer treatment industry in third-tier and below cities will develop rapidly to meet the increasing demand.
Private hospitals have great development potential.
In recent years, influenced by a series of policies issued by the state, such as restricting the expansion of public hospitals and encouraging the society to run hospitals, private specialized hospitals have obvious advantages in development. For example, 20 19 Notice of the National Health and Wellness Committee on Printing and Distributing Opinions on Promoting the Sustainable and Healthy Development of Social Medical Services proposed that the number and scale of public hospitals should be strictly controlled to leave enough space for the development of social medical services.
In 20 19, the revenue of cancer medical service in public hospitals nationwide was 336.7 billion yuan, while that in private hospitals was 336.7 billion yuan. Although public hospitals dominate the cancer medical service market in terms of income share, private hospitals are growing faster in terms of income growth.
In 20 15-20 19, the compound annual growth rate of cancer medical service income in private hospitals nationwide was 23.7%, and that in public hospitals was 1 1.7%. In the future, private hospitals in the cancer treatment industry in China have great development potential.
-For more data, please refer to the Analysis Report on Market Prospect and Investment Strategic Planning of Anticancer Drugs Industry in China by Prospective Industry Research Institute.